Chronic, non-healing wounds pose on-going challenges for clinicians and are painful, costly and affect the quality of life for patients. Although there are lots of wound care products available, we have chosen to higlight products in our first issue with exciting technology and evidence-based research that have already been game-changers for many wounds. Look inside to discover promising, innovative products that just may be the key to healing your patients’ wounds.
Learn about unique products formulated from a specialized protein that are considered the “closer” for wounds.
The skin is one of the body’s main barrier systems against microbes entering the body and multiplying. When the skin is compromised, for instance, if an injury which breaks that protective barrier is sustained, tissues in the wound bed become…
Markus Stucker, Karl-Christian Munter, Cornelia Erfurt-Berge, Steffen Luzkendorf, Stephan Eder, Udo Moller and Joachim Dissemond
Chronic venous insufficiency (CVI) of the lower limbs is a common condition affecting 5-30% of the adult population worldwide, with a prevalence that is consistently increasing with age. Caused by functional abnormality of the venous….
Mark Greer looks at the efforts being undertaken to tackle antibiotic resistance.
In 1845, an expedition lead by Sir John Franklin set sail from England to find the Northwest passage. Their fate remains one of the great maritime mysteries.
Victorian Arctic exploration was notoriously dangerous and some crew members were dead and buried before the expedition disappeared in the frozen Canadian seas…
Christine Murphy, Leanne Atkin, Joachim Dissemond, Jennifer Hurlow, Yih Kai Tan,
Jan Apelqvist, Nathalie Salles, Jun Wu, Masahiro Tachi and Randall Wolcott.
A biofilm-based approach to wound care has already been defined. However, it has previously been questioned if we are waiting too long before starting biofilm-based wound care (BBWC). It is widely accepted that biofilm is present in the majority of hard-to-heal wounds and is a barrier to healing. While biofilm is not necessarily visible to the naked eye….
The economic burden of wounds in the US costs Medicare an estimated $28 billion to $96.8 billion annually. The associated costs of care and risk for severe complications (such as infection or amputation) increases the longer a wound remains open. A stall in wound closure may be due to a variety of systemic and local factors…
Hard-to-heal wounds can disrupt patients’ every day life, cause pain, and lead to extra costs. To support clinicians, evidence-based research, clinical expertise, and new wound care technologies offer effective solutions and support for non-healing wounds. Learn how the following unique products may benefit your patients’ wounds…
Here we provide an overview of recently published articles that may be of interest to wound care professionals. Should you wish to look at any of the papers in more detail, a full reference is provided…